Medical Product Alert N° 11/2019: Falsified Amoxicillin + Clavulanic Acid products
Opening remarks at meeting on dissemination of national biosafety regulation and laboratory quality standards and the progress on strengthening health laboratory and epidemiology systems in Lao PDR
Special mapping of existing TB training curricula and related materials
WHO welcomes vital new funding for the Global Fund
The use of non-pharmaceutical forms of Artemisia
WHO Statement on higher than normal incidence of aggregation in Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus Influenzae Type B vaccine, ready to use (liquid) single-dose presentation, produced by Biological E. Limited, India
Vaccines in national immunization programme update
New evidence shows significant mistreatment of women during childbirth
Report of the WHO Information Session for civil society representatives on the WHO guidelines development process with focus on TB guidelines
New WHO evidence on mistreatment of women during childbirth
